BURN OINTMENT MARKET ANALYSIS

A burn occurs when skin tissue is damaged by heat, chemicals, sunlight, electricity, or radiation. The majority of burns are caused due to accidents. There are various degrees of burns- first degree, second degree and third degree burns. First-degree burns are minor (like most sunburns). The top layer of skin (epidermis) turns red and painful, but it usually does not blister. Second-degree burns affect the top and bottom layers of the skin (dermis). Pain, redness, swelling, and blistering are all possible side effects. Third-degree burns affect all three layers of the skin: the epidermis, dermis, and fat.

Burn ointment is a topically administered treatment applied on the burnt area of our body and is available in the form of gels, creams, oils and sprays. After cooling the burn injury with water, burn ointments are applied to heal the burn wounds. The types of ointment used depends upon the severity of burns. For example, some people use aloe vera gel as a home remedy to treat sunburns. While antibiotic creams are used to treat thermal burns. However, for the treatment of second and third degree burns, the healthcare provider may prescribe a stronger antibiotic cream containing silver, such as silver sulfadiazine, to prevent possible bacterial infections.

Market Dynamics

Market players are focused on research and development activities to obtain approvals for new products or techniques associated with burn injuries, which could contribute to the growth of the global burn ointment market over the forecast period. For instance, in Oct 2020, Recce Pharmaceuticals Ltd announced that it has received Human Research Ethics Committee (HREC) approval to begin a Phase I/II clinical trial of its broad-spectrum antibiotic RECCE 327 on patients with infected burn wounds.

Market players are focusing on product launches, which is expected to strengthen their position in the global burn ointment market. For instance, on May 1, 2020, LUMASOL, a new health tech player in the skincare industry, launched its first product lumasol, a broad-spectrum SPF 50 mist with a unique, translucent, and cruelty-free formula that helps prevent sun-related disease such as sunburns and ageing.

Market players are involved in expanding their global presence by adopting strategies such as acquisitions and partnerships, this is expected to drive the growth of the global burn ointment market globally. For instance, in May 2019, Vericel Corp., an American biopharmaceutical company announced an exclusive U.S. licensing and supply agreement with MediWound Ltd., a fully-integrated biopharmaceutical company for its NexoBrid biological product.

Key features of the study:

• This report provides an in-depth analysis of global burn ointment market, provides market size (US$ Million), and compound annual growth rate (CAGR %) for the forecast period (2021-2028), considering 2020 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
• It profiles leading players in the global burn ointment market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
• Key companies covered as a part of this study include Smith & Nephew PLC, Wisconsin Pharmacal Company, Johnson & Johnson, Pfizer Inc., Cipla Ltd., Mankind Pharma Ltd., Dr. Morepen Ltd., and GlaxoSmithKline PLC.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
• The global burn ointment market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision making through various strategy matrices used in analyzing the global burn ointment market.

Detailed Segmentation:

• Global Burn Ointment Market, By Product Type:
  • Topical Antibiotics
  • Silver
  • Iodine
• Global Burn Ointment Market, By Depth of Burn:
  • Minor Burns
  • Partial Thickness Burns
  • Full Thickness Burns
• Global Burn Ointment Market, By End User:
  • Hospitals
  • Specialty Clinics
  • Others
• Global Burn Ointment Market, By Region:
  • North America
    • By Product Type:
      • Topical Antibiotics
      • Silver
      • Iodine
    • By Depth of Burn:
      • Minor Burns
      • Partial Thickness Burns
      • Full thickness Burns
    • By End User:
      • Hospitals
      • Specialty Clinics
      • Others
    • By Country:
      • U.S.
      • Canada
  • Latin America
    • By Product Type:
      • Topical Antibiotics
      • Silver
      • Iodine
    • By Depth of Burn:
      • Minor Burns
      • Partial Thickness Burns
      • Full thickness Burns
    • By End User:
      • Hospitals
      • Specialty Clinics
      • Others
    • By Country:
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • By Product Type:
      • Topical Antibiotics
      • Silver
      • Iodine
    • By Depth of Burn:
      • Minor Burns
      • Partial Thickness Burns
      • Full thickness Burns
    • By End User:
      • Hospitals
      • Specialty Clinics
      • Others
    • By Country:
      • U.K.
      • Germany
      • Italy
      • Spain
      • France
      • Russia
      • Rest of Europe
  • Asia Pacific
    • By Product Type:
      • Topical Antibiotics
      • Silver
      • Iodine
    • By Depth of Burn:
      • Minor Burns
      • Partial Thickness Burns
      • Full thickness Burns
    • By End User:
      • Hospitals
      • Specialty Clinics
      • Others
    • By Country
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • By Product Type:
      • Topical Antibiotics
      • Silver
      • Iodine
    • By Depth of Burn:
      • Minor Burns
      • Partial Thickness Burns
      • Full thickness Burns
    • By End User:
      • Hospitals
      • Specialty Clinics
      • Others
    • By Country:
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • By Product Type:
      • Topical Antibiotics
      • Silver
      • Iodine
    • By Depth of Burn:
      • Minor Burns
      • Partial Thickness Burns
      • Full thickness Burns
    • By End User:
      • Hospitals
      • Specialty Clinics
      • Others
    • By Country/Region:
      • South Africa
      • Central Africa
      • North Africa
• Company Profiles
  • Smith & Nephew PLC*
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
  • Wisconsin Pharmacal Company
  • Johnson & Johnson
  • Pfizer Inc.
  • Cipla Ltd.
  • Mankind Pharma Ltd.
  • Morepen Ltd.
  • GlaxoSmithKline PLC

 “*” marked represents similar segmentation in other categories in the respective section.